Abstract
Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective treatment against Enterocytozoon bieneusi, one of the two main species causing the microsporidiosis involved in human diseases. We report the first case, to our knowledge, of a probable drug-induced aseptic meningoencephalitis, after administration of fumagillin in a kidney transplant recipient with microsporidiosis.
© 2012 John Wiley & Sons A/S.
MeSH terms
-
Antifungal Agents / adverse effects*
-
Cyclohexanes / adverse effects*
-
Cyclohexanes / therapeutic use
-
Fatty Acids, Unsaturated / adverse effects*
-
Fatty Acids, Unsaturated / therapeutic use
-
Female
-
Humans
-
Immunocompromised Host
-
Kidney Transplantation / adverse effects*
-
Meningoencephalitis / etiology*
-
Microsporidiosis / drug therapy*
-
Middle Aged
-
Sesquiterpenes / adverse effects
-
Sesquiterpenes / therapeutic use
Substances
-
Antifungal Agents
-
Cyclohexanes
-
Fatty Acids, Unsaturated
-
Sesquiterpenes
-
fumagillin